A Randomized, Open-Label Study to Compare the Safety and Efficacy of Cyclosporine Dose Reduction With Cyclosporine Elimination in De Novo Renal Allograft Recipients Receiving Rapamune.
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2011
At a glance
- Drugs Ciclosporin; Sirolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Wyeth
- 23 Jul 2007 Status change
- 13 Dec 2005 New trial record.